Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

3.63
+0.11003.12%
Pre-market: 3.54-0.0900-2.48%06:21 EDT
Volume:2.26M
Turnover:8.27M
Market Cap:655.25M
PE:-2.68
High:3.75
Open:3.59
Low:3.59
Close:3.52
52wk High:6.94
52wk Low:1.11
Shares:180.51M
Float Shares:99.80M
Volume Ratio:0.76
T/O Rate:2.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3521
EPS(LYR):-1.3521
ROE:-146.81%
ROA:-40.68%
PB:5.42
PE(LYR):-2.68

Loading ...

Prime Medicine Inc: Files for Mixed Shelf Offering - SEC Filing

THOMSON REUTERS
·
Nov 07, 2025

Prime Medicine : Sales Agreement Prospectus Covers Offer, Sale of Shares of Common Stock of up to $200 Mln From Time to Time

THOMSON REUTERS
·
Nov 07, 2025

Prime Medicine Q3 EPS $(0.32) Misses $(0.26) Estimate, Sales $1.225M Beat $1.026M Estimate

Benzinga
·
Nov 07, 2025

Prime Medicine Unveils Pipeline Progress and Clinical Milestones for Prime Editing Platform

Reuters
·
Nov 07, 2025

Prime Medicine Q3 net loss narrows

Reuters
·
Nov 07, 2025

BRIEF-Prime Medicine, Inc. Q3 EPS USD -0.32

Reuters
·
Nov 07, 2025

Prime Medicine Appoints Matthew Hawryluk as Chief Business Officer

Reuters
·
Nov 07, 2025

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Nov 07, 2025

Prime Medicine, Inc. Q3 Operating Expenses USD 55.198 Million

THOMSON REUTERS
·
Nov 07, 2025

Prime Medicine Appoints Matthew Hawryluk, Ph.d., M.b.a. as Chief Business Officer

THOMSON REUTERS
·
Nov 03, 2025

Press Release: Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Dow Jones
·
Nov 03, 2025

Prime Medicine Showcases Wilson’s Disease Strategy at Virtual KOL Event

Reuters
·
Oct 31, 2025

H.C. Wainwright Sticks to Its Hold Rating for Prime Medicine, Inc. (PRME)

TIPRANKS
·
Oct 22, 2025

Prime Medicine, Inc.'s (NASDAQ:PRME) 6.6% loss last week hit both individual investors who own 30% as well as institutions

Simply Wall St.
·
Oct 13, 2025

Septerna Inc. Appoints Biotechnology Veteran Keith Gottesdiener, M.D., to Board of Directors as Chair of Newly Formed R&D Committee

Reuters
·
Sep 30, 2025

Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today

TIPRANKS
·
Sep 11, 2025